Mario Riera-Romo

6PUBLICATIONS
10CO-AUTHORS
Innate immunityPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2025
Linking TLR-7 Signaling to Downregulation of Placental P-Glycoprotein: Implications for Fetal Drug Exposure.

Mario Riera-Romo, Eliza R McColl, Micheline Piquette-Miller

|Jul 27, 2022
Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta.

Valerio Taggi, Mario Riera Romo, Micheline Piquette-Miller

|Jan 30, 2022
Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models.

Yolanda Gomez Rodriguez, Brizaida Oliva Arguelles, Mario Riera-Romo

|Mar 08, 2021
Cell death as part of innate immunity: Cause or consequence?

Mario Riera Romo

|May 22, 2020
Antitumour peptide based on a protein derived from the horseshoe crab: CIGB-552 a promising candidate for cancer therapy.

Brizaida Oliva Arguelles, Mario Riera-Romo, Maribel Guerra Vallespi

|May 26, 2017
COMMD1: A Multifunctional Regulatory Protein.

Mario Riera-Romo

Pageof 1

Frequent Collaborators

2 joint publications

Micheline Piquette-Miller

1 joint publications

Valerio Taggi

1 joint publications

Henriette E Meyer Zu Schwabedissen

1 joint publications

Sibylle Neuhoff